切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2021, Vol. 15 ›› Issue (05) : 298 -302. doi: 10.3877/cma.j.issn.1674-3903.2021.05.009

综述

肝肺联合移植临床研究进展
赵晋1, 陈静瑜2,()   
  1. 1. 214023 南京医科大学附属无锡人民医院肺移植中心
    2. 214023 南京医科大学附属无锡人民医院肺移植中心;310009 杭州,浙江大学医学院附属第二医院肺移植科
  • 收稿日期:2021-04-15 出版日期:2021-10-25
  • 通信作者: 陈静瑜
  • 基金资助:
    江苏省医学杰出人才计划(JCRCB2016003)

Clinical research progress of combined liver and lung transplantation

Jin Zhao1, Jingyu Chen2,()   

  1. 1. Lung Transplant Center, Wuxi People′s Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China
    2. Lung Transplant Center, Wuxi People′s Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China; Department of Lung Transplantation, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
  • Received:2021-04-15 Published:2021-10-25
  • Corresponding author: Jingyu Chen
引用本文:

赵晋, 陈静瑜. 肝肺联合移植临床研究进展[J]. 中华移植杂志(电子版), 2021, 15(05): 298-302.

Jin Zhao, Jingyu Chen. Clinical research progress of combined liver and lung transplantation[J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(05): 298-302.

当患者合并终末期肝病和终末期肺病且预估单器官移植无法存活时,肝肺联合移植(CLLT)是目前唯一可行的治疗方法。由于手术难度较高及供器官短缺,世界范围内仅少数移植中心报道过相关案例。本文回顾当前CLLT的相关文献,综述其适应证、术式选择、并发症及预后等。

The combined liver-lung transplantation (CLLT) is performed in patients with dual-organ failure in whom survival is not expected with single-organ transplantation alone. Due to the difficulty of the operation and the scarcity of donated organs, only a few transplant centers worldwide have reported relevant cases. This review evaluates the existing literature regarding CLLT, describing the indication, operation choosing, complications, and prognosis.

表1 肝肺联合移植适应证[2]
1
Zhang T, Price MB, Bravo N, et al. Combined lung-liver and delayed kidney transplantation for cystic fibrosis clinical approach and outcome: A case report[J]. Transplant Proc, 2020, 52(9): 2824-2826.
2
Han JL, Beal EW, Mumtaz K, et al. Combined liver-lung transplantation: Indications, outcomes, current experience and ethical issues[J]. Transplant Rev (Orlando), 2019, 33(2):99-106.
3
Adams B, Chiem D, Wang C, et al. Combined bilateral lung-liver transplantation complicated by intraoperative right ventricular dysfunction and postoperative hepatic artery thrombosis[J]. J Cardiothorac Vasc Anesth, 2013, 27(6): 1343-1346.
4
Chryssostalis A, Hubert D, Coste J, et al. Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation[J]. J Hepatol, 2011, 55(6): 1377-1382.
5
Couetil JP, Houssin DP, Soubrane O, et al. Combined lung and liver transplantation in patients with cystic fibrosis. A 4 1/2-year experience[J]. J Thorac Cardiovasc Surg, 1995, 110(5): 1415-1422.
6
Debray D, Kelly D, Houwen R, et al. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease[J]. J Cyst Fibros, 2011, 10 Suppl 2: S29-S36.
7
Christie JD, Bavaria JE, Palevsky HI, et al. Primary graft failure following lung transplantation[J]. Chest, 1998, 114(1): 51-60.
8
Desai CS, Gruessner A, Habib S, et al. Survival of cystic fibrosis patients undergoing liver and liver-lung transplantations[J]. Transplant Proc, 2013, 45(1): 290-292.
9
Freischlag KW, Messina J, Ezekian B, et al. Single-center long-term analysis of combined liver-lung transplant outcomes[J]. Transplant Direct, 2018, 4(5): e349.
10
Grannas G, Neipp M, Hoeper MM, et al. Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases[J]. Transplantation, 2008, 85(4): 524-531.
11
Barshes NR, DiBardino DJ, McKenzie ED, et al. Combined lung and liver transplantation: the United States experience[J]. Transplantation, 2005, 80(9): 1161-1167.
12
Pirenne J, Verleden G, Nevens F, et al. Combined liver and (heart-) lung transplantation in liver transplant candidates with refractory portopulmonary hypertension[J]. Transplantation, 2002, 73(1): 140-142.
13
Yi SG, Burroughs SG, Loebe M, et al. Combined lung and liver transplantation: analysis of a single-center experience[J]. Liver Transpl, 2014, 20(1): 46-53.
14
Gadre S, Turowski J, Budev M. Overview of lung transplantation, heart-lung transplantation, liver-lung transplantation, and combined hematopoietic stem cell transplantation and lung transplantation[J]. Clin Chest Med, 2017, 38(4):623-640.
15
Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014-an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation[J]. J Heart Lung Transplant, 2015, 34(1): 1-15.
16
Scheiermann P, Czerner S, Kaspar M, et al. Combined lung and liver transplantation with extracorporeal membrane oxygenation instead of cardiopulmonary bypass[J]. J Cardiothorac Vasc Anesth, 2016, 30(2): 437-442.
17
Machuca TN, Collaud S, Mercier O, et al. Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation[J]. J Thorac Cardiovasc Surg, 2015, 149(4): 1152-1157.
18
Couetil JP, Soubrane O, Houssin DP, et al. Combined heart-lung-liver, double lung-liver, and isolated liver transplantation for cystic fibrosis in children[J]. Transpl Int, 1997, 10(1): 33-39.
19
Van De Wauwer C, Verschuuren EA, Nossent GD, et al. A staged approach for a lung-liver transplant patient using ex vivo reconditioned lungs first followed by an urgent liver transplantation[J]. Transpl Int, 2015, 28(1): 129-133.
20
Grimm JC, Valero V 3rd, Kilic A, et al. Association between prolonged graft ischemia and primary graft failure or survival following lung transplantation[J]. JAMA Surg, 2015, 150(6): 547-553.
21
Yeung JC, Krueger T, Yasufuku K, et al. Outcomes after transplantation of lungs preserved for more than 12 h: a retrospective study[J]. Lancet Respir Med, 2017, 5(2): 119-124.
22
Salman J, Grannas G, Ius F, et al. The liver-first approach for combined lung and liver transplantation[J]. Eur J Cardiothorac Surg, 2018, 54(6):1122-1127.
23
Ceulemans LJ, Monbaliu D, Verslype C, et al. Combined liver and lung transplantation with extended normothermic lung preservation in a patient with end-stage emphysema complicated by drug-induced acute liver failure[J]. Am J Transplant, 201414(10): 2412-2416.
24
Rana A, Robles S, Russo MJ, et al. The combined organ effect: protection against rejection?[J]. Ann Surg, 2008, 248(5): 871-879.
25
Olausson M, Mjörnstedt L, Nordén G, et al. Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients[J]. Am J Transplant, 2007, 7(1): 130-136.
26
Ceulemans LJ, Strypstein S, Neyrinck A, et al. Combined liver-thoracic transplantation: single-center experience with introduction of the 'liver-first’ principle[J]. Transpl Int, 2016, 29(6): 715-726.
27
Ceulemans LJ, Vos R, Neyrinck A, et al. Liver-first versus lung-first: a new dilemma in combined organ transplantation[J]. Transpl Int, 2018, 31(2): 230-231.
28
Hadjiliadis D, Steele MP, Chaparro C, et al. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria[J]. J Heart Lung Transplant, 2007, 26(8): 834-838.
29
Husain S, Sole A, Alexander BD, et al. The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary[J]. J Heart Lung Transplant, 2016, 35(3):261-282.
30
Fishman JA. Infection in organ transplantation[J]. Am J Transplant, 2017, 17(4): 856-879.
31
Scouras NE, Matsusaki T, Boucek CD, et al. Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation[J]. Liver Transpl, 2011, 17(2): 137-143.
32
Corno V, Dezza MC, Lucianetti A, et al. Combined double lung-liver transplantation for cystic fibrosis without cardio-pulmonary by-pass[J]. Am J Transplant, 2007, 7(10): 2433-2438.
33
Le Rond S, Le Maoult J, Créput C, et al. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients[J]. Eur J Immunol, 2004, 34(3): 649-660.
34
Bhama JK, Pilewski JM, Zaldonis D, et al. Does simultaneous lung-liver transplantation provide an immunologic advantage compared with isolated lung transplantation?[J]. J Thorac Cardiovasc Surg, 2011, 141(5): e36-e38.
35
Faro A, Shepherd R, Huddleston CB, et al. Lower incidence of bronchiolitis obliterans in pediatric liver-lung transplant recipients with cystic fibrosis[J]. Transplantation, 2007, 83(11): 1435-1439.
36
Crispe IN. Immune tolerance in liver disease[J]. Hepatology, 2014, 60(6): 2109-2117.
37
Arnon R, Annunziato RA, Miloh T, et al. Liver and combined lung and liver transplantation for cystic fibrosis: analysis of the UNOS database[J]. Pediatr Transplant, 2011, 15(3): 254-264.
[1] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[2] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[3] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[4] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[5] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[6] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[7] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[8] 鲁鑫, 许佳怡, 刘洋, 杨琴, 鞠雯雯, 徐缨龙. 早期LC术与PTCD续贯LC术治疗急性胆囊炎对患者肝功能及预后的影响比较[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 648-650.
[9] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[10] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[11] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[12] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要